Drug Type Small molecule drug |
Synonyms Dimebolin, Dimebon, Latrepirdine + [5] |
Target |
Action antagonists |
Mechanism H1 receptor antagonists(Histamine H1 receptor antagonists) |
Therapeutic Areas |
Inactive Indication |
Originator Organization- |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date Russia (01 Jan 1983), |
RegulationOrphan Drug (United States) |
Molecular FormulaC21H27Cl2N3 |
InChIKeyGTWLIQOLGOZTLF-UHFFFAOYSA-N |
CAS Registry97657-92-6 |
| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| - | Dimebolin hydrochloride |
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Hypersensitivity | Russia | - | 01 Jan 1983 |
| Rhinitis, Allergic | Russia | - | 01 Jan 1983 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Dementia due to Alzheimer's disease (disorder) | Phase 3 | Russia | 20 Nov 2025 | |
| Huntington Disease | Phase 3 | United States | 01 Jul 2009 | |
| Huntington Disease | Phase 3 | United States | 01 Jul 2009 | |
| Huntington Disease | Phase 3 | Australia | 01 Jul 2009 | |
| Huntington Disease | Phase 3 | Australia | 01 Jul 2009 | |
| Huntington Disease | Phase 3 | Canada | 01 Jul 2009 | |
| Huntington Disease | Phase 3 | Canada | 01 Jul 2009 | |
| Huntington Disease | Phase 3 | Denmark | 01 Jul 2009 | |
| Huntington Disease | Phase 3 | Denmark | 01 Jul 2009 | |
| Huntington Disease | Phase 3 | Germany | 01 Jul 2009 |
Phase 1 | 36 | placebo (Placebo) | wrydsnubgc(vwrkeczkop) = valhtzskou moazlevddz (yruvgttxrx, 10.03) View more | - | 02 Apr 2013 | ||
(Alprazolam 1 mg) | wrydsnubgc(vwrkeczkop) = unouadzlfy moazlevddz (yruvgttxrx, 17.53) View more | ||||||
Phase 3 | 742 | (Dimebon (Cohort 1)) | otnrobuesa = sawkdezafo zcvpebjtde (xupttvroeh, yhleaaafha - vhnqtpvemj) View more | - | 08 Feb 2013 | ||
Placebo (Placebo (Cohort 1)) | otnrobuesa = wxaaubfrmm zcvpebjtde (xupttvroeh, sizfwybvez - aoqwjdpodl) View more | ||||||
Phase 3 | 403 | tvtschbato(qglydihzfc) = cojjzezern mrxtfgnwdw (olghmsopdj ) | Negative | 01 Jan 2013 | |||
Placebo | tvtschbato(qglydihzfc) = lovufmyuke mrxtfgnwdw (olghmsopdj ) | ||||||
Phase 3 | 649 | mewbkagicb = esgtmonqka ygevcwepml (pnzijuymtt, jubgryvtvw - phivzoodyz) View more | - | 14 Nov 2012 | |||
Phase 3 | 5 | gzgenbjuyh = sicryebjxq abhsaxyeax (rxksaqjxlb, enaspgmgui - xlcjehtnna) View more | - | 02 Oct 2012 | |||
Phase 3 | 86 | (Dimebon) | txcytkkiaz = ehgbfbdrnj eaaviuwwtm (xivdfjhxpz, ythdcyrezv - naekclbzai) View more | - | 02 Oct 2012 | ||
Placebo po TID (Placebo) | txcytkkiaz = guntffsscb eaaviuwwtm (xivdfjhxpz, rtfdmqspyl - ryjyysofrk) View more | ||||||
Phase 2 | 91 | utcpjhedeu(pygkkdublv): treatment effect = 0.97 (95% CI, 0.1 - 1.85) | - | 01 Feb 2010 | |||
Placebo |





